
The agency probably will accept the reauthorization, and you would think that would be a good thing. But the untold story of the legislation — known as ADUFA for the Animal Drug User Fee Act — is that the FDA is forgoing opportunities to compel companies to disclose data that it would be in the public’s interest to know.
Click "source" to read more.


